These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 9848433)
1. Is prophylactic treatment after myocardial infarction evidence-based? Brotons C; Calvo F; Cascant P; Ribera A; Moral I; Permanyer-Miralda G Fam Pract; 1998 Oct; 15(5):457-61. PubMed ID: 9848433 [TBL] [Abstract][Full Text] [Related]
2. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. Barron HV; Michaels AD; Maynard C; Every NR J Am Coll Cardiol; 1998 Aug; 32(2):360-7. PubMed ID: 9708461 [TBL] [Abstract][Full Text] [Related]
3. Trends in long-term management of survivors of acute myocardial infarction by cardiologists in a government university-affiliated teaching hospital. Mitra S; Findley K; Frohnapple D; Mehta JL Clin Cardiol; 2002 Jan; 25(1):16-8. PubMed ID: 11808833 [TBL] [Abstract][Full Text] [Related]
4. The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Komajda M; Follath F; Swedberg K; Cleland J; Aguilar JC; Cohen-Solal A; Dietz R; Gavazzi A; Van Gilst WH; Hobbs R; Korewicki J; Madeira HC; Moiseyev VS; Preda I; Widimsky J; Freemantle N; Eastaugh J; Mason J; Eur Heart J; 2003 Mar; 24(5):464-74. PubMed ID: 12633547 [TBL] [Abstract][Full Text] [Related]
5. Modern adjunctive pharmacotherapy of myocardial infarction. Prasad A; Reeder G Expert Opin Pharmacother; 2000 Mar; 1(3):405-18. PubMed ID: 11249526 [TBL] [Abstract][Full Text] [Related]
6. Effect of an educational program on the prevalence of use of antiplatelet drugs, beta blockers, angiotensin-converting enzyme inhibitors, lipid-lowering drugs, and calcium channel blockers prescribed during hospitalization and at hospital discharge in patients with coronary artery disease. Sanal S; Aronow WS J Gerontol A Biol Sci Med Sci; 2003 Nov; 58(11):1046-8. PubMed ID: 14630888 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological profile of survivors of acute myocardial infarction at Turkish academic hospitals. Ergin A; Abaci A; Sakalli A; Eryol NK; Oguzhan A; Unal S; Cetin S Int J Cardiol; 1999 Mar; 68(3):309-16. PubMed ID: 10213283 [TBL] [Abstract][Full Text] [Related]
8. Practical algorithms for pharmacologic management of the post myocardial infarction patient. Reiffel JA; ; Clin Cardiol; 2005 Nov; 28(11 Suppl 1):I28-37. PubMed ID: 16450810 [TBL] [Abstract][Full Text] [Related]
9. The management of patients who have suffered an acute myocardial infarction in a tertiary care centre. Haddad H; Searles G; Gillis A Can J Cardiol; 2001 Feb; 17(2):179-83. PubMed ID: 11223488 [TBL] [Abstract][Full Text] [Related]
10. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction. Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577 [TBL] [Abstract][Full Text] [Related]
11. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence. Simpson E; Beck C; Richard H; Eisenberg MJ; Pilote L Am Heart J; 2003 Mar; 145(3):438-44. PubMed ID: 12660666 [TBL] [Abstract][Full Text] [Related]
12. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs]. Noll G; Kaufmann U; Wenzel RR; Lüscher TF Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687 [TBL] [Abstract][Full Text] [Related]
13. Pathophysiologic bases for adjunctive therapies in the treatment and secondary prevention of acute myocardial infarction. Gutstein DE; Fuster V Clin Cardiol; 1998 Mar; 21(3):161-8. PubMed ID: 9541759 [TBL] [Abstract][Full Text] [Related]
14. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction. Kizer JR; Cannon CP; McCabe CH; Mueller HS; Schweiger MJ; Davis VG; Perritt R; Antman EM Am Heart J; 1999 Jan; 137(1):79-92. PubMed ID: 9878939 [TBL] [Abstract][Full Text] [Related]
15. Pharmacologic therapies after myocardial infarction. Rapaport E; Gheorghiade M Am J Med; 1996 Oct; 101(4A):4A61S-69S; discussion 4A69S-70S. PubMed ID: 8900339 [TBL] [Abstract][Full Text] [Related]
16. Trends of prescribing patterns for the secondary prevention of myocardial infarction over a 13-year period. Martínez M; Agustí A; Arnau JM; Vidal X; Laporte JR Eur J Clin Pharmacol; 1998 May; 54(3):203-8. PubMed ID: 9681660 [TBL] [Abstract][Full Text] [Related]
17. [Drug prescription in myocardial postinfarction: results of the EPPI (étude de prescription postinfarctus). A French cooperative study]. Boissel JP; Némoz C; Gillet J; Salewski B; Diaz N Arch Mal Coeur Vaiss; 1990 Nov; 83(12):1777-82. PubMed ID: 1980055 [TBL] [Abstract][Full Text] [Related]
18. Medication in relation to ST-segment elevation myocardial infarction in patients with a first myocardial infarction: Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA). Björck L; Wallentin L; Stenestrand U; Lappas G; Rosengren A Arch Intern Med; 2010 Aug; 170(15):1375-81. PubMed ID: 20696964 [TBL] [Abstract][Full Text] [Related]
19. Survival prospects after acute myocardial infarction in the UK: a matched cohort study 1987-2011. Gitsels LA; Kulinskaya E; Steel N BMJ Open; 2017 Jan; 7(1):e013570. PubMed ID: 28119386 [TBL] [Abstract][Full Text] [Related]
20. [Drug therapy of coronary heart disease--are therapeutic guidelines being paid attention to?]. Böger GI; Hoopmann M; Busse R; Budinger M; Welte T; Böger RH Z Kardiol; 2003 Jun; 92(6):466-75. PubMed ID: 12819995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]